Hericium erinaceus mycelium ameliorate anxiety induced by continuous sleep disturbance in vivo

Abstract Background Sleep disruption is a major public health issue and may increase the risk of mortality by ten-folds if an individual is sleeping less than 6 h per night. Sleep has changed dramatically during to the COVID-19 pandemic because COVID symptoms can lead to psychological distress inclu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tsung-Ju Li, Tung-Yen Lee, Yun Lo, Li-Ya Lee, I-Chen Li, Chin-Chu Chen, Fang-Chia Chang
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/83d086dfddea4c12814f1ab4f7ca1739
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:83d086dfddea4c12814f1ab4f7ca1739
record_format dspace
spelling oai:doaj.org-article:83d086dfddea4c12814f1ab4f7ca17392021-12-05T12:23:58ZHericium erinaceus mycelium ameliorate anxiety induced by continuous sleep disturbance in vivo10.1186/s12906-021-03463-32662-7671https://doaj.org/article/83d086dfddea4c12814f1ab4f7ca17392021-12-01T00:00:00Zhttps://doi.org/10.1186/s12906-021-03463-3https://doaj.org/toc/2662-7671Abstract Background Sleep disruption is a major public health issue and may increase the risk of mortality by ten-folds if an individual is sleeping less than 6 h per night. Sleep has changed dramatically during to the COVID-19 pandemic because COVID symptoms can lead to psychological distress including anxiety. Hericium erinaceus mycelium has been widely investigated in both the in vivo studies and clinical trials for its neuroprotective functions because the mycelium contains hericenones and erinacines, which synthesize the nerve growth factor and brain-derived neurotrophic factor (BDNF). Recent in vivo reports have shown showed that erinacine A-enriched Hericium erinaceus mycelium can modulate BDNF/TrkB/PI3K/Akt/GSK-3β pathways to induce an antidepressant-like effect. A large body of evidence indicates that erinacine can pass the blood-brain barrier and suggests its neuroprotective function in both peripheral and central nervous systems. Thus, Hericium erinaceus mycelium may be a dual-function supplement for sleep disruption improvement while sustaining anxiolytic effects. Method To simulate the condition of sleep disruption, the mice were subjected to the tail suspension test (TST) for 15 min every day during the same period for nine consecutive days. Two different doses (75 and 150 mg/kg) of Hericium erinaceus mycelium were administered orally 20 min prior to the TSTs before entering the light period of 12:12 h L:D cycle. All sleep-wake recording was recorded for 24 h using electroencephalogram and electromyogram. The elevated-plus-maze and open-field tests were conducted to record the behavior activities. Results Consecutive TSTs prior to the light period could cause significant sleep disturbance and anxiety behavior in the elevated-plus-maze experiments. Results showed that administration with Hericium erinaceus mycelium at 150 mg/kg ameliorated the rodent anxiety (p < 0.05) and reversed the TST-induced NREM sleep disturbance in the dark period. Conclusion This is the first in vivo study suggesting that Hericium erinaceus mycelium has a dual potential role for anxiety relief through improving sleep disruptions.Tsung-Ju LiTung-Yen LeeYun LoLi-Ya LeeI-Chen LiChin-Chu ChenFang-Chia ChangBMCarticleHericium erinaceus myceliumCOVID-19SleepAnxietyNREMOther systems of medicineRZ201-999ENBMC Complementary Medicine and Therapies, Vol 21, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Hericium erinaceus mycelium
COVID-19
Sleep
Anxiety
NREM
Other systems of medicine
RZ201-999
spellingShingle Hericium erinaceus mycelium
COVID-19
Sleep
Anxiety
NREM
Other systems of medicine
RZ201-999
Tsung-Ju Li
Tung-Yen Lee
Yun Lo
Li-Ya Lee
I-Chen Li
Chin-Chu Chen
Fang-Chia Chang
Hericium erinaceus mycelium ameliorate anxiety induced by continuous sleep disturbance in vivo
description Abstract Background Sleep disruption is a major public health issue and may increase the risk of mortality by ten-folds if an individual is sleeping less than 6 h per night. Sleep has changed dramatically during to the COVID-19 pandemic because COVID symptoms can lead to psychological distress including anxiety. Hericium erinaceus mycelium has been widely investigated in both the in vivo studies and clinical trials for its neuroprotective functions because the mycelium contains hericenones and erinacines, which synthesize the nerve growth factor and brain-derived neurotrophic factor (BDNF). Recent in vivo reports have shown showed that erinacine A-enriched Hericium erinaceus mycelium can modulate BDNF/TrkB/PI3K/Akt/GSK-3β pathways to induce an antidepressant-like effect. A large body of evidence indicates that erinacine can pass the blood-brain barrier and suggests its neuroprotective function in both peripheral and central nervous systems. Thus, Hericium erinaceus mycelium may be a dual-function supplement for sleep disruption improvement while sustaining anxiolytic effects. Method To simulate the condition of sleep disruption, the mice were subjected to the tail suspension test (TST) for 15 min every day during the same period for nine consecutive days. Two different doses (75 and 150 mg/kg) of Hericium erinaceus mycelium were administered orally 20 min prior to the TSTs before entering the light period of 12:12 h L:D cycle. All sleep-wake recording was recorded for 24 h using electroencephalogram and electromyogram. The elevated-plus-maze and open-field tests were conducted to record the behavior activities. Results Consecutive TSTs prior to the light period could cause significant sleep disturbance and anxiety behavior in the elevated-plus-maze experiments. Results showed that administration with Hericium erinaceus mycelium at 150 mg/kg ameliorated the rodent anxiety (p < 0.05) and reversed the TST-induced NREM sleep disturbance in the dark period. Conclusion This is the first in vivo study suggesting that Hericium erinaceus mycelium has a dual potential role for anxiety relief through improving sleep disruptions.
format article
author Tsung-Ju Li
Tung-Yen Lee
Yun Lo
Li-Ya Lee
I-Chen Li
Chin-Chu Chen
Fang-Chia Chang
author_facet Tsung-Ju Li
Tung-Yen Lee
Yun Lo
Li-Ya Lee
I-Chen Li
Chin-Chu Chen
Fang-Chia Chang
author_sort Tsung-Ju Li
title Hericium erinaceus mycelium ameliorate anxiety induced by continuous sleep disturbance in vivo
title_short Hericium erinaceus mycelium ameliorate anxiety induced by continuous sleep disturbance in vivo
title_full Hericium erinaceus mycelium ameliorate anxiety induced by continuous sleep disturbance in vivo
title_fullStr Hericium erinaceus mycelium ameliorate anxiety induced by continuous sleep disturbance in vivo
title_full_unstemmed Hericium erinaceus mycelium ameliorate anxiety induced by continuous sleep disturbance in vivo
title_sort hericium erinaceus mycelium ameliorate anxiety induced by continuous sleep disturbance in vivo
publisher BMC
publishDate 2021
url https://doaj.org/article/83d086dfddea4c12814f1ab4f7ca1739
work_keys_str_mv AT tsungjuli hericiumerinaceusmyceliumameliorateanxietyinducedbycontinuoussleepdisturbanceinvivo
AT tungyenlee hericiumerinaceusmyceliumameliorateanxietyinducedbycontinuoussleepdisturbanceinvivo
AT yunlo hericiumerinaceusmyceliumameliorateanxietyinducedbycontinuoussleepdisturbanceinvivo
AT liyalee hericiumerinaceusmyceliumameliorateanxietyinducedbycontinuoussleepdisturbanceinvivo
AT ichenli hericiumerinaceusmyceliumameliorateanxietyinducedbycontinuoussleepdisturbanceinvivo
AT chinchuchen hericiumerinaceusmyceliumameliorateanxietyinducedbycontinuoussleepdisturbanceinvivo
AT fangchiachang hericiumerinaceusmyceliumameliorateanxietyinducedbycontinuoussleepdisturbanceinvivo
_version_ 1718371967421120512